{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-115093","form_type":"8-K","ticker":"PAHC","cik":"0001069899","company_name":"PHIBRO ANIMAL HEALTH CORP","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.116968+00:00","generated_at":"2026-06-08T13:15:19.274153+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Phibro Animal Health faces FDA actions to revoke Mecadox approval; $20M sales at risk","bullets":["FDA issued final order revoking approved method for detecting carbadox residues in swine.","FDA proposed to withdraw all new animal drug applications for Mecadox in swine feed; Phibro may request hearing.","Mecadox sales for fiscal year ended June 30, 2023 were approximately $20 million.","Phibro states it is extremely disappointed, believes in safety, and will defend Mecadox's continued use.","Company notes 50+ year history of safe use and intends to take appropriate action against FDA's steps."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-115093","json":"https://secwatch.observer/filing/0001104659-23-115093.json","markdown":"https://secwatch.observer/filing/0001104659-23-115093.md","text":"https://secwatch.observer/filing/0001104659-23-115093.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1069899/000110465923115093/0001104659-23-115093-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1069899/000110465923115093/tm2330063d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T13:15:19.274153+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}